ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Therapeutic Solutions International Launches Veltmeyer Institute for Advanced Biologics

FDA Phase III Stem Cell Company Offers End Stage Patients Access to FDA Cleared Clinical Trial Stem Cells

Therapeutic Solutions International (TSOI) announced the launching of the Veltmeyer Institute for Advanced Biologics (www.veltmeyerinstitute.org). The organization is focused on providing patients access to JadiCell adult stem cells in the field of brain and lung conditions under the Right to Try Law in applicable cases.

The Veltmeyer Institute is believed to be the only organization providing allogeneic stem cells that have been cleared by the FDA for clinical trials. The Veltmeyer Institute leverages the experience of Dr. James Veltmeyer who has treated over 100 patients under the Right to Try Law in collaboration with Therapeutic Solutions International and other Biotechnology Companies.

“I have always been a strong believer that patients should not have to leave the United States to receive access to the most cutting-edge technologies,” said Dr. James Veltmeyer, who is Chief Medical Officer of Therapeutic Solutions International and Founder of the Institute that bears his name. “I am proud to have assembled a first-class team of medical and marketing professionals to develop the Veltmeyer Institute as the premium destination for patients with incurable conditions who seek access to regenerative medicine approaches as well as immunotherapy for end stage cancer.”

“I speak for the whole TSOI Family that Dr. Veltmeyer is by far the kindest, most knowledgeable, and most effective medical doctor that we have worked quietly with all these years,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “I am proud that we have been successful in creating this Institute which will provide a base for providing patient rapid access to stem cells and other treatments in a safe and legal way in the United States of America.”

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.21
-3.89 (-1.56%)
AAPL  273.97
-1.28 (-0.47%)
AMD  256.63
+19.11 (8.05%)
BAC  54.09
+0.46 (0.87%)
GOOG  287.44
-4.30 (-1.47%)
META  611.88
-15.20 (-2.42%)
MSFT  511.13
+2.45 (0.48%)
NVDA  192.68
-0.48 (-0.25%)
ORCL  227.78
-8.37 (-3.54%)
TSLA  431.66
-7.96 (-1.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.